This is a double-blind, randomized, placebo-controlled, 2-period crossover, 2-cohort study in adult patients with refractory chronic cough. The purpose of the study is to assess the efficacy and safety of inhaled PA101 delivered via eFlow high efficiency nebulizer for treating refractory chronic cough.
The study consists of 2 treatment cohorts with refractory chronic cough: Idiopathic Pulmonary Fibrosis (IPF, Cohort 1) and Chronic Idiopathic Cough (CIC, Cohort 2). In each cohort, the study will include two treatment periods of 14 days each separated by a Washout Period of 14 days between Period 1 and Period 2. The two periods will be identical except that in Period 2, patients will crossover to the alternate treatment from that received in Period 1, according to a 1:1 randomization scheme. During each period, patients will self-administer study drug (i.e., 40 mg PA101 or Placebo PA101 via eFlow) three times daily for 14 consecutive days of each period. Objective cough count will be recorded over 24-hour period using a cough count device (Leicester Cough Monitor) at the Baseline, Day 7 and Day 14 of each treatment period. In the IPF cohort, patients will be allowed to use antifibrotic therapy (i.e., pirfenidone, nintedanib, and N-acetylcysteine) during the course of the study provided that the dose is stabilized at least 3 months prior to Screening and throughout the study period. Clinical safety assessments will be performed at the start and end of each treatment period.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
52
Erasmus Medical Center
Rotterdam, Netherlands
Isala
Zwolle, Netherlands
Hull Clinical Trials Unit
Cottingham, East Yorkshire, United Kingdom
Uni Hospital Leicester
Leicester, United Kingdom
cough frequency
objective 24-hour cough monitoring
Time frame: 14 days
cough severity
VAS scale for cough severity
Time frame: 14 days
cough-related quality of life
Leicester Cough Questionnaire
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
King's College Hospital
London, United Kingdom
Royal Brompton & Harefield Hospital
London, United Kingdom
Uni Hospital North Staffordshire
Stoke-on-Trent, United Kingdom